New treatment option for Dysphagia
Official title External Pharyngeal Exerciser and Dysphagia
ClinicalTrials.gov ID: NCT05708898
What this study is testing
- What it's testing
- The goal of this a clinical trial is to test the effect of a pharyngeal exerciser in rehabilitation of pharyngeal phase of swallowing in patients with dysphagia. The main question it aims to answer is: Does application of pharyngeal exerciser improve swallowing as evidenced by need for prescribed intervention for dysphagia (maneuvers, exercises or dietary modification to prevent aspiration).
- Which group you join is decided by chance.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 and older. Healthy volunteers may be eligible.
You may be able to join if
- Patients with dysphagia characterized by persistent pharyngeal residue on fluoroscopic study undergoing rehabilitative intervention (e.g.: exercises...
- Healthy elderly adult (≥65 years of age).
You likely can't join if
- Patients younger than 18 years of age.
- Patients with recent head and neck cancer (\<1 month post-surgery or \<3 months post-chemo radiation.
- Patients suffering from muscle diseases like muscular dystrophies, myopathies.
- Patients with neuro-muscular junction disorders myasthenia gravis, Eaton-Lambert disorders
- Patients having history of allergy to lidocaine or barium.
- Patients who are pregnant or lactating.
See the full eligibility criteria
- Patients with dysphagia characterized by persistent pharyngeal residue on fluoroscopic study undergoing rehabilitative intervention (e.g.: exercises, maneuvers or dietary modification) for improving swallowing and...
- Healthy elderly adult (≥65 years of age).
- Patients younger than 18 years of age.
- Patients with recent head and neck cancer (\<1 month post-surgery or \<3 months post-chemo radiation.
- Patients suffering from muscle diseases like muscular dystrophies, myopathies.
- Patients with neuro-muscular junction disorders myasthenia gravis, Eaton-Lambert disorders
- Patients having history of allergy to lidocaine or barium.
- Patients who are pregnant or lactating.
- Patients who are medically unstable.
- Patients who are unable to apply the exerciser independently or with the help of a caregiver.
- Patients who lack cognition.
The study team makes the final eligibility decision.
Where it's taking place
- Milwaukee, Wisconsin, United States
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years and older. Healthy volunteers may be eligible. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Milwaukee, Wisconsin, United States. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.